AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 8th, 2022 • Oyster Point Pharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 8th, 2022 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of November 7, 2022 (the “Agreement Date”), by and among Viatris Inc., a Delaware corporation (“Parent”), Iris Purchaser Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and Oyster Point Pharma, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement shall have the meanings ascribed to such terms in Article 1.